Chengdu Kanghong Pharmaceutical Group Co., Ltd

Research Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ) on Bullrun: market cap CNY 17.91B, P/E 18.3, dividend yield 3.6%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is CNY 17.91B; P/E is 18.3; dividend yield is 3.6%.

Peer valuation comparison

Latest P/E is 18.34x versus a Healthcare sector median of 21.75x (15.7% below).

Latest dividend yield is 3.6% versus a Healthcare sector median of 2.4% (50.0% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-18CNY 17.91B18.33.6%0.7

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0.7 CNY, yield 3.6%.

About Chengdu Kanghong Pharmaceutical Group Co., Ltd

Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It develops medicines for ophthalmic, neuropsychiatric, and others. The company was founded in 1996 and is headquartered in Chengdu, China.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Chengdu Kanghong Pharmaceutical Group Co., Ltd's market cap?

Chengdu Kanghong Pharmaceutical Group Co., Ltd's market capitalization is CNY 17.91B.

What is Chengdu Kanghong Pharmaceutical Group Co., Ltd's P/E ratio?

Chengdu Kanghong Pharmaceutical Group Co., Ltd's price-to-earnings (P/E) ratio is 18.3.

Does Chengdu Kanghong Pharmaceutical Group Co., Ltd pay a dividend?

Chengdu Kanghong Pharmaceutical Group Co., Ltd has a dividend yield of 3.6%.

What does Chengdu Kanghong Pharmaceutical Group Co., Ltd do?

Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It develops medicines for ophthalmic, neuropsychiatric, and others. The company was founded in 1996 and is headquartered in Chengdu, China.